SAU:4018

Almoosa Health Company · SAU · Healthcare · SAR · FY for 2025

Figures on this page computed 2026-11-08 13:22 UTC

Last close

n/aSAR

Market data

  • 19.8xP/E

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed
    • Computed from the filing for 2025
  • 7.5%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 16.7%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -24.5%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.42Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    SAR
    • computed

Follow one riyal

lens 1 of 9
After what it costs to make
31.7%
After running the business
14.5%
After interest and tax
16.7%
After what it must reinvest
-24.5%
Kept after the dividend
-30.6%
after what it costs to make, 31.7% of sales; after running the business, 14.5% of sales; after interest and tax, 16.7% of sales; after what it must reinvest, -24.5% of sales; kept after the dividend, -30.6% of sales

The five stops

5 of 5 read
  • After what it costs to make448,600,00031.7%
  • After running the business204,784,30214.5%
  • After interest and tax236,541,39716.7%
  • After what it must reinvest-347,061,330-24.5%
  • Kept after the dividend-433,453,311-30.6%

Of every unit of sales, -0.31 is still there after the dividend.

Of every unit of sales, -0.31 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales1,416,300,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • After what it costs to make448,600,000
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • After running the business204,784,302
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • After interest and tax236,541,397
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • After what it must reinvest-347,061,330
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR
  • Kept after the dividend-433,453,311
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    SAR

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.